7Baggers
 published on: 2025-11-12 21:47:16  newser.com Thu, 13 Nov 2025 03:47:16 GMT
 published on: 2025-11-12 16:30:24  newser.com Wed, 12 Nov 2025 22:30:24 GMT
 November 2025's Promising Penny Stocks To Watch  simplywall.st Wed, 12 Nov 2025 17:08:45 GMT
 published on: 2025-11-12 02:14:40  newser.com Wed, 12 Nov 2025 08:14:40 GMT
 Allogene Therapeutics (ALLO) Receives a Buy from H.C. Wainwright  The Globe and Mail Wed, 12 Nov 2025 06:25:00 GMT
 allogene therapeutics readies for key healthcare investor conferences  Traders Union Mon, 10 Nov 2025 14:15:44 GMT
 published on: 2025-11-10 05:00:19  newser.com Mon, 10 Nov 2025 11:00:19 GMT
 published on: 2025-11-09 13:51:07  newser.com Sun, 09 Nov 2025 19:51:07 GMT
 allogene therapeutics’ earnings call: cautious optimism  The Globe and Mail Sun, 09 Nov 2025 06:36:38 GMT
 allogene therapeutics’ earnings call: cautious optimism  TipRanks Sat, 08 Nov 2025 00:26:51 GMT
 allogene trims losses and pushes ahead with drug trials  Finimize Fri, 07 Nov 2025 10:26:32 GMT
 Allogene Posts Narrower-Than-Expected Loss in Q3, Nil Sales  Yahoo Finance Fri, 07 Nov 2025 08:00:00 GMT
 Allogene Therapeutics’ Earnings Call: Cautious Optimism  TipRanks Fri, 07 Nov 2025 08:00:00 GMT
 Allogene Therapeutics (ALLO) Gets a Buy from Oppenheimer  The Globe and Mail Fri, 07 Nov 2025 08:00:00 GMT
 earnings call transcript: allogene therapeutics q3 2025 beats eps expectations  Investing.com Nigeria Fri, 07 Nov 2025 07:49:16 GMT
 Allogene Therapeutics Advances in CAR T Therapy Development  TipRanks Fri, 07 Nov 2025 05:14:12 GMT
 allogene therapeutics reports q3 eps (19c), consensus (23c)  TipRanks Fri, 07 Nov 2025 03:30:21 GMT
 allogene therapeutics: q3 earnings snapshot  Norwalk Hour Fri, 07 Nov 2025 00:51:35 GMT
 allogene q3 net loss narrows to $41.4 mln  MarketScreener Thu, 06 Nov 2025 22:35:58 GMT
 allogene therapeutics: q3 earnings snapshot  Barchart.com Thu, 06 Nov 2025 21:26:37 GMT
 published on: 2025-11-06 03:44:16  newser.com Thu, 06 Nov 2025 09:44:16 GMT
 published on: 2025-11-05 04:42:51  newser.com Wed, 05 Nov 2025 10:42:51 GMT
 published on: 2025-11-05 00:44:04  newser.com Wed, 05 Nov 2025 06:44:04 GMT
 published on: 2025-11-04 03:05:29  fcp.pa.gov.br Tue, 04 Nov 2025 06:05:29 GMT
 allogene to present pivotal trial design for lymphoma therapy at ash  Investing.com Nigeria Tue, 04 Nov 2025 03:09:58 GMT
 allogene to present pivotal trial design for lymphoma therapy at ash  Investing.com Mon, 03 Nov 2025 08:00:00 GMT
 published on: 2025-11-02 23:31:58  newser.com Mon, 03 Nov 2025 07:31:58 GMT
 published on: 2025-11-02 02:58:33  newser.com Sun, 02 Nov 2025 07:58:33 GMT
 published on: 2025-11-01 21:58:39  newser.com Sun, 02 Nov 2025 02:58:39 GMT

Allogene Therapeutics, Inc
(NASDAQ:ALLO) 

ALLO stock logo

Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candi...

Founded: 2017
Full Time Employees: 264
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends